版本:
中国

BRIEF-Immune receives nasdaq letter

April 24 Immune Pharmaceuticals Inc

* Immune receives Nasdaq letter

* Got notice from listing qualifications department of Nasdaq notifying that Co does not comply with Nasdaq's filing requirements Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐